artificial intelligence tools flu copilotdeveloped by a Canadian company Alcan Angel Artificial Intelligencehas become the winning project of this collection “Pediatric Innovation Challenge Program” sponsor AstraZeneca beside i4KIDS, Center for Pediatric Innovationcoordinated by Saint Joan Dede Hospital and has international influence.
The purpose of the challenge is to identify initiatives that provide new solutions and strategies for: Reduce the social impact of pediatric influenza. Key needs identified included awareness, prevention strategies and vaccination coverage. The Flu-Copilot virtual assistant has been selected by AstraZeneca out of 22 projects received. The pharmaceutical company will inject up to €50,000 into the program and will be involved in its final development.
As Arkangel AI President and Co-Founder Laura Velásquez explained to Innovaspain, these types of projects typically do not take priority in a company’s strategy. “The work we do in more than 18 countries is 100% focused on the health industry and its institutions: hospitals, governments, health personnel, pharmaceutical companies or insurance companies. We try to detect whether artificial intelligence can solve different problems. In this case Next, we automatically transform the data into an intelligent model. “The new algorithm is derived from an algorithm. “
different terrain
Regarding the AstraZeneca proposal, Velazquez confirmed that they found it “interesting” because it involves patients, boys and girls, and their caregivers (mainly fathers and mothers) to address various aspects of pediatric influenza. Experts believe her AI tool will improve different situations. “We have extensive experience in early detection of cancer, cardiovascular, respiratory and renal diseases and in adherence to different treatments,” he added.
In the specific case of pediatric influenza, Arkangel AI hopes to reduce the saturation experienced by health systems at the peak of the disease. “In those days, hospitals and health centers were overcrowded and the quality of care deteriorated dramatically. The service was difficult to manage. Boys and girls suffered the most as these care deficiencies led to an increased chance of complications. Other related challenges to be addressed include detailed monitoring Flu vaccination and prioritizing care for the sickest patients.”
Laura Velásquez details that her line of action includes a virtual AI assistant that caregivers can use in real time on any device. “This will help them understand the condition of the children more accurately. The idea is to integrate the assistant into the health system. This way, it will actively participate in making appointments and even recommend a trip to the emergency room, based on the patient’s condition.”
scientific rigor
Answers to parent questions are based on scientific literature. “Let us not make the mistake of thinking that this assistant is a GPT Chat, but a powerful tool based on clinical protocols. In addition to meeting all the requirements of a health system, the system strives to provide a solution carefully curated with scientific evidence, otherwise It’s impossible to do that.”
The final configuration, operation and content of Flu-Copilot will result from the coordination of: Alcan Angel Artificial Intelligence In partnership with AstraZeneca and the Sant Joan de Deu hospital, if all goes well, the technology company plans to conduct the first tests there. “The model will be trained for about three months, after which it will go into the hospital’s own channels (Velásquez’s ideal solution) or as an external tool. It is important to receive feedback from nursing staff, the most common questions, outline the details… a little Later, we intend to expand this to other countries, including areas where access to hospitals or medical professionals is more complex.”
Drugs, key components
he Dr. César Velasco, Director of Innovation and Digital Strategy, AstraZeneca Highlights that innovation ecosystems can help improve childhood influenza vaccination by applying innovative technologies with social and health approaches. “We are keen to improve accessibility and information related to Vaccinationto protect the most vulnerable from this virus,” he added.
“AstraZeneca is a big player “Within the health system,” Laura Velásquez said. “Pharmaceutical companies are the drivers of innovative services such as Flu-Copilot. They seek to ensure that vaccines or other treatments reach the right people at the right time. The initiative also plays an important role in combating disinformation. When we look at health issues The answer is when we are used to consuming pure garbage. In our previous journey, when health sector players saw the results of using new technologies, they put aside their fears and eliminated uncertainty. “They were more willing to explore Other possibilities for innovation support. ”